You are here

Family Bank: HealthBaby

HealthBaby

About

HealthBaby Biotech (Hong Kong) Co., Ltd. (HealthBaby) is a subsidiary of Cordlife Group Limited, a SGX mainboard listed company founded in 2001. The Group is a pioneer in private cord blood banking in Asia and operates Asia's largest network of cord blood banks. With full stem cell banking laboratories in six key markets, Cordlife Group is an industry leader in Singapore, Hong Kong, Indonesia, and the Philippines, and one of the top three market leaders in India and Malaysia. Through its majority-owned subsidiary in Malaysia, StemLife Berhad, Cordlife holds an indirect stake in Thailand’s largest private cord blood bank, THAI StemLife.  

HealthBaby is Hong Kong's most accredited cord blood laboratory (including AABB, FACT, and CAP). HealthBaby is the most recommended by Hong Kong O&G doctors1 and the most entrusted by parents for 14 consecutive years2. The Group has obtained 90% market share in Hong Kong3. HealthBaby offers comprehensive banking of cord blood and umbilical cord lining. HealthBaby owns an exclusive Hong Kong patent for the processing of cord tissue as well as processing, storage and culturing technologies.

Labs and Locations

HealthBaby is the first cord blood bank established in Hong Kong Science & Technology Park, equipped with the most advanced infrastructure. As the largest cord blood bank with a floor area of more than 10,000 square feet in Hong Kong, HealthBaby's laboratory is equipped with advanced biotechnology backup facilities, 24-hour security system and high class clean rooms.

Office and laboratory: Unit 703-706, 7/F Lakeside 2 West Wing, No. 10 Science Park West Avenue, Hong Kong Science Park, Shatin, N.T. Hong Kong

Business Experience

HealthBaby was established and dedicated to cord blood industry since 2006. HealthBaby goes beyond just providing the cord blood and umbilical cord stem cell storage services. The Company devotes time and resources in biotechnology research projects to explore stem cell medical applications for the betterment of human health. HealthBaby also participated in various projects, including "Therapeutic Implications of Human Umbilical Cord Mesenchymal Stromal Cells in Attenuating Influenza A(H5N1) Virus–Associated Acute Lung Injury", "In Vivo Mouse Model to Study the Therapeutic Effect of Umbilical Cord Derived Mesenchymal Stem Cells on Severe Human Influenza Diseases", and HPV Vaccine with international and local universities and official organizations.

The Cordlife Group is composed of:​

  • Cordlife Group Limited – Singapore
  • Cordlife (Hong Kong) Limited - Hong Kong & Macau
  • Health Baby Biotech (Hong Kong) Co., Limited – Hong Kong & Macau
  • Cordlife Sciences India Pvt Limited - India & Bangladesh
  • PT Cordlife Persada - Indonesia
  • Cordlife Medical Philippines, Inc. – the Philippines
  • StemLife Berhad – Malaysia & Brunei
  • THAI StemLife - Thailand, Myanmar, Laos, Cambodia

Quality and customer focus are amongst some of the cornerstones of Cordlife. All of the Group’s facilities are accredited by AABB, the world’s gold standard for cord blood banking. Cordlife Singapore and Healthbaby Hong Kong are the only two private cord blood banks in Asia and among five worldwide to be accredited by both AABB and the Foundation for the Accreditation of Cellular Therapy (FACT), another world-class accreditation body for cord blood banks worldwide.  In the area of clinical diagnostics, Cordlife India and HealthBaby are accredited by the College of American Pathologists (CAP). 

References cited:

  1. IMS Cord Blood Bank Market Research in Hong Kong (with Private O&G physicians)
  2. Ipsos Healthcare 2009 – 2022 Cord Blood Bank Survey
  3. Ipsos Healthcare 2022 Cord Blood Bank Survey

Collection Kit

HealthBaby provides specialised cord blood and umbilical cord collection kits with the necessary collection tools (e.g. JMS blood bags, syringe and vacutainers etc.) and detailed collection guidelines to O&G doctors.

Transportation container

HealthBaby's container is thermal-insulated to provide stable storage condition. A data logger is used to monitor the temperature throughout the transportation process to ensure the cord blood sample is kept within the optimal temperature range.

Shipping Info

HealthBaby provides in-house free-of-charge cord blood and umbilical cord samples collection service from designated hospitals (Hong Kong and Macau region) upon notification.

Processing Method

HealthBaby adopts a specialized, FDA-cleared stem cells processing system: AXP® AutoXpress® Platform. AXP® consistently retrieves 98.7% MonoNuclear Cells (MNC) and 96.2% Total Nucleated Cells (TNC), which is about 18% higher than other systems, based on research published in US Obstetrics & Gynaecology (Willert, Purdon, Harris 2008).

Components Stored

HSC: Hematopoietic Stem Cells, MSC: Mesenchymal Stromal Cells, Cord Tissue

Storage Method

HealthBaby is the only private cord blood bank in Hong Kong that adopts the state-of-the-art and FDA-cleared automatic stem cell storage system: BioArchive® System. The BioArchive® freezer has a closed system and automatic retrieval operation to eliminate temperature fluctuation when the lid of the storage tank is opened. Liquid nitrogen (-196℃) storage medium provides stable temperature and maintains the highest cell viability.  BioArchive® has been adopted by 170 cord blood banks in 42 countries worldwide, including the Hong Kong public cord blood bank as of January 2020.

Licensing & Accreditation

Besides AABB accreditation, HealthBaby is the first and only cord blood laboratory in Hong Kong accredited by the College of American Pathologists (CAP), and Foundation for the Accreditation of Cellular Therapy (FACT). HealthBaby is one out of the four cord blood banks in the world to achieve this triple accreditation. These achievements are the best validations of HealthBaby’s services.

Clinical Experience

To date, the Group has successfully released 71 cord blood units and 8 cord lining units to support stem cell transplantation and infusions.

In Hong Kong, HealthBaby has released the most cord blood units of any bank. Three patients were successfully treated with their own cord blood. Two of the recipients were suffering from cerebral palsy and one was suffering from neuroblastoma. One recipient received a transplant of sibling cord blood to treat Fanconi's Anaemia. One recipient received an allogeneic cord blood transplant in 2011 to treat Thalassemia Major.

Insurance

HealthBaby offers full refund and compensation policies to protect their clients' interests covering aspects of cord blood delivery, man-made negligence or accidents. HealthBaby is also the first cord blood bank to commit to a full refund and provides worldwide cord blood replacement or compensation up to US$50,000. The Company also has a SG$10 million Professional Indemnity Insurance to further provide protection for their clients. HealthBaby issues a stem cell viability report to their clients annually to demonstrate sample integrity.

Prices

Please call HealthBaby hotline to find out more about our service plans. Interest-free instalment payment is available upon request. You may also visit: https://www.healthbaby.hk/en-hk/service-plan for more information.

  • Hong Kong: +852 3188 8899
  • Macau: +853 2878 6717

Additional Services

HLA Typing Service is available as optional service.

Phone:
HK Hotline: +852 3188 8899
Macau Hotline: +853 2878 6717
Address: Lakeside 2 West Wing, 10 Science Park West Avenue, Science Park, Shatin, N.T. Hong Kong (Office Unit 703-706 7F, Lab Unit G02-05 G/F)